The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.

MLA

Tanaka, Yoshiya, et al. “The 2023 Guidelines for the Management and Treatment of Glucocorticoid-Induced Osteoporosis.” Journal of Bone & Mineral Metabolism, vol. 42, no. 2, Mar. 2024, pp. 143–54. EBSCOhost, https://doi.org/10.1007/s00774-024-01502-w.

APA

Tanaka, Y., Soen, S., Hirata, S., Okada, Y., Fujiwara, S., Tanaka, I., Kitajima, Y., Kubota, T., Ebina, K., Takashi, Y., Inoue, R., Yamauchi, M., Okubo, N., Ueno, M., Ohata, Y., Ito, N., Ozono, K., Nakayama, H., Terauchi, M., & Tanaka, S. (2024). The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of Bone & Mineral Metabolism, 42(2), 143–154. https://doi.org/10.1007/s00774-024-01502-w

Chicago

Tanaka, Yoshiya, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, et al. 2024. “The 2023 Guidelines for the Management and Treatment of Glucocorticoid-Induced Osteoporosis.” Journal of Bone & Mineral Metabolism 42 (2): 143–54. doi:10.1007/s00774-024-01502-w.